nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—CALM1—Alzheimer's disease	0.364	0.805	CbGaD
Loperamide—CYP2D6—Alzheimer's disease	0.0884	0.195	CbGaD
Loperamide—CYP2B6—Memantine—Alzheimer's disease	0.0721	0.275	CbGbCtD
Loperamide—CYP2D6—Rivastigmine—Alzheimer's disease	0.0502	0.192	CbGbCtD
Loperamide—CYP2D6—Donepezil—Alzheimer's disease	0.0402	0.153	CbGbCtD
Loperamide—CYP3A4—Rivastigmine—Alzheimer's disease	0.0319	0.122	CbGbCtD
Loperamide—CYP2D6—Galantamine—Alzheimer's disease	0.0259	0.0987	CbGbCtD
Loperamide—CYP3A4—Donepezil—Alzheimer's disease	0.0255	0.0974	CbGbCtD
Loperamide—CYP3A4—Galantamine—Alzheimer's disease	0.0165	0.0627	CbGbCtD
Loperamide—POMC—locus ceruleus—Alzheimer's disease	0.0156	0.201	CbGeAlD
Loperamide—CACNA1A—cerebellar cortex—Alzheimer's disease	0.0122	0.156	CbGeAlD
Loperamide—POMC—telencephalic ventricle—Alzheimer's disease	0.00741	0.0952	CbGeAlD
Loperamide—POMC—blood vessel—Alzheimer's disease	0.00367	0.0471	CbGeAlD
Loperamide—Bullous eruption—Memantine—Alzheimer's disease	0.00297	0.0398	CcSEcCtD
Loperamide—Bullous eruption—Rivastigmine—Alzheimer's disease	0.0029	0.0389	CcSEcCtD
Loperamide—OPRM1—telencephalic ventricle—Alzheimer's disease	0.00279	0.0358	CbGeAlD
Loperamide—Abdominal bloating—Donepezil—Alzheimer's disease	0.00271	0.0364	CcSEcCtD
Loperamide—Epigastric pain—Donepezil—Alzheimer's disease	0.00267	0.0358	CcSEcCtD
Loperamide—Altered state of consciousness—Memantine—Alzheimer's disease	0.00254	0.0341	CcSEcCtD
Loperamide—POMC—forebrain—Alzheimer's disease	0.00194	0.0249	CbGeAlD
Loperamide—CACNA1A—forebrain—Alzheimer's disease	0.00185	0.0237	CbGeAlD
Loperamide—Ileus—Donepezil—Alzheimer's disease	0.00183	0.0245	CcSEcCtD
Loperamide—POMC—telencephalon—Alzheimer's disease	0.00178	0.0229	CbGeAlD
Loperamide—CACNA1A—telencephalon—Alzheimer's disease	0.0017	0.0218	CbGeAlD
Loperamide—Ileus—Memantine—Alzheimer's disease	0.00166	0.0222	CcSEcCtD
Loperamide—Urinary retention—Galantamine—Alzheimer's disease	0.00115	0.0154	CcSEcCtD
Loperamide—Depressed level of consciousness—Memantine—Alzheimer's disease	0.00113	0.0152	CcSEcCtD
Loperamide—Abdominal pain upper—Galantamine—Alzheimer's disease	0.00111	0.0148	CcSEcCtD
Loperamide—OPRD1—forebrain—Alzheimer's disease	0.00107	0.0137	CbGeAlD
Loperamide—POMC—nervous system—Alzheimer's disease	0.00105	0.0135	CbGeAlD
Loperamide—OPRK1—forebrain—Alzheimer's disease	0.00102	0.0131	CbGeAlD
Loperamide—POMC—central nervous system—Alzheimer's disease	0.00101	0.013	CbGeAlD
Loperamide—CACNA1A—nervous system—Alzheimer's disease	0.001	0.0129	CbGeAlD
Loperamide—CALM2—blood vessel—Alzheimer's disease	0.001	0.0129	CbGeAlD
Loperamide—CALM1—blood vessel—Alzheimer's disease	0.000997	0.0128	CbGeAlD
Loperamide—POMC—cerebellum—Alzheimer's disease	0.000989	0.0127	CbGeAlD
Loperamide—OPRD1—telencephalon—Alzheimer's disease	0.000982	0.0126	CbGeAlD
Loperamide—Dermatitis bullous—Donepezil—Alzheimer's disease	0.000982	0.0132	CcSEcCtD
Loperamide—CACNA1A—central nervous system—Alzheimer's disease	0.000966	0.0124	CbGeAlD
Loperamide—CACNA1A—cerebellum—Alzheimer's disease	0.000944	0.0121	CbGeAlD
Loperamide—Urinary retention—Donepezil—Alzheimer's disease	0.000892	0.012	CcSEcCtD
Loperamide—Dermatitis bullous—Memantine—Alzheimer's disease	0.000891	0.0119	CcSEcCtD
Loperamide—Dermatitis bullous—Rivastigmine—Alzheimer's disease	0.000872	0.0117	CcSEcCtD
Loperamide—Abdominal pain upper—Donepezil—Alzheimer's disease	0.000857	0.0115	CcSEcCtD
Loperamide—Urinary tract disorder—Galantamine—Alzheimer's disease	0.000827	0.0111	CcSEcCtD
Loperamide—Urethral disorder—Galantamine—Alzheimer's disease	0.000821	0.011	CcSEcCtD
Loperamide—Abdominal distension—Donepezil—Alzheimer's disease	0.000816	0.0109	CcSEcCtD
Loperamide—Urinary retention—Memantine—Alzheimer's disease	0.00081	0.0109	CcSEcCtD
Loperamide—POMC—brain—Alzheimer's disease	0.000803	0.0103	CbGeAlD
Loperamide—Urinary retention—Rivastigmine—Alzheimer's disease	0.000793	0.0106	CcSEcCtD
Loperamide—CACNA1A—brain—Alzheimer's disease	0.000767	0.00985	CbGeAlD
Loperamide—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.000761	0.0102	CcSEcCtD
Loperamide—Immune system disorder—Galantamine—Alzheimer's disease	0.000757	0.0101	CcSEcCtD
Loperamide—OPRM1—forebrain—Alzheimer's disease	0.000728	0.00935	CbGeAlD
Loperamide—Flatulence—Galantamine—Alzheimer's disease	0.000718	0.00963	CcSEcCtD
Loperamide—OPRM1—telencephalon—Alzheimer's disease	0.00067	0.0086	CbGeAlD
Loperamide—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.000651	0.00872	CcSEcCtD
Loperamide—Drowsiness—Rivastigmine—Alzheimer's disease	0.000642	0.0086	CcSEcCtD
Loperamide—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000641	0.00859	CcSEcCtD
Loperamide—Loss of consciousness—Galantamine—Alzheimer's disease	0.000641	0.00859	CcSEcCtD
Loperamide—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.000637	0.00853	CcSEcCtD
Loperamide—Urethral disorder—Donepezil—Alzheimer's disease	0.000636	0.00852	CcSEcCtD
Loperamide—CALM3—telencephalon—Alzheimer's disease	0.000619	0.00795	CbGeAlD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000616	0.00826	CcSEcCtD
Loperamide—Discomfort—Galantamine—Alzheimer's disease	0.000613	0.00822	CcSEcCtD
Loperamide—Dry mouth—Galantamine—Alzheimer's disease	0.000607	0.00813	CcSEcCtD
Loperamide—CALM2—embryo—Alzheimer's disease	0.000598	0.00768	CbGeAlD
Loperamide—CALM1—embryo—Alzheimer's disease	0.000595	0.00764	CbGeAlD
Loperamide—Nervous system disorder—Galantamine—Alzheimer's disease	0.000584	0.00782	CcSEcCtD
Loperamide—Urinary tract disorder—Memantine—Alzheimer's disease	0.000582	0.0078	CcSEcCtD
Loperamide—OPRD1—nervous system—Alzheimer's disease	0.00058	0.00745	CbGeAlD
Loperamide—Skin disorder—Galantamine—Alzheimer's disease	0.000578	0.00774	CcSEcCtD
Loperamide—Urethral disorder—Memantine—Alzheimer's disease	0.000578	0.00774	CcSEcCtD
Loperamide—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000569	0.00763	CcSEcCtD
Loperamide—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000565	0.00757	CcSEcCtD
Loperamide—OPRD1—central nervous system—Alzheimer's disease	0.000558	0.00717	CbGeAlD
Loperamide—Erythema multiforme—Memantine—Alzheimer's disease	0.000557	0.00747	CcSEcCtD
Loperamide—Flatulence—Donepezil—Alzheimer's disease	0.000557	0.00746	CcSEcCtD
Loperamide—OPRK1—nervous system—Alzheimer's disease	0.000556	0.00714	CbGeAlD
Loperamide—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000545	0.0073	CcSEcCtD
Loperamide—OPRK1—central nervous system—Alzheimer's disease	0.000535	0.00687	CbGeAlD
Loperamide—Immune system disorder—Memantine—Alzheimer's disease	0.000532	0.00713	CcSEcCtD
Loperamide—Somnolence—Galantamine—Alzheimer's disease	0.000529	0.00709	CcSEcCtD
Loperamide—CALM2—forebrain—Alzheimer's disease	0.000529	0.00679	CbGeAlD
Loperamide—CALM1—forebrain—Alzheimer's disease	0.000526	0.00676	CbGeAlD
Loperamide—Dyspepsia—Galantamine—Alzheimer's disease	0.000524	0.00702	CcSEcCtD
Loperamide—OPRK1—cerebellum—Alzheimer's disease	0.000523	0.00672	CbGeAlD
Loperamide—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000514	0.00688	CcSEcCtD
Loperamide—Fatigue—Galantamine—Alzheimer's disease	0.000513	0.00687	CcSEcCtD
Loperamide—Constipation—Galantamine—Alzheimer's disease	0.000509	0.00682	CcSEcCtD
Loperamide—Flatulence—Memantine—Alzheimer's disease	0.000506	0.00677	CcSEcCtD
Loperamide—Loss of consciousness—Donepezil—Alzheimer's disease	0.000497	0.00665	CcSEcCtD
Loperamide—Flatulence—Rivastigmine—Alzheimer's disease	0.000495	0.00663	CcSEcCtD
Loperamide—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000487	0.00652	CcSEcCtD
Loperamide—CALM2—telencephalon—Alzheimer's disease	0.000486	0.00624	CbGeAlD
Loperamide—CALM1—telencephalon—Alzheimer's disease	0.000484	0.00621	CbGeAlD
Loperamide—Discomfort—Donepezil—Alzheimer's disease	0.000475	0.00637	CcSEcCtD
Loperamide—Dry mouth—Donepezil—Alzheimer's disease	0.00047	0.0063	CcSEcCtD
Loperamide—Abdominal pain—Galantamine—Alzheimer's disease	0.00047	0.0063	CcSEcCtD
Loperamide—Nervous system disorder—Donepezil—Alzheimer's disease	0.000452	0.00606	CcSEcCtD
Loperamide—Loss of consciousness—Memantine—Alzheimer's disease	0.000451	0.00604	CcSEcCtD
Loperamide—OPRD1—brain—Alzheimer's disease	0.000443	0.00569	CbGeAlD
Loperamide—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000441	0.00591	CcSEcCtD
Loperamide—Hypersensitivity—Galantamine—Alzheimer's disease	0.000438	0.00587	CcSEcCtD
Loperamide—Discomfort—Memantine—Alzheimer's disease	0.000432	0.00578	CcSEcCtD
Loperamide—Dry mouth—Memantine—Alzheimer's disease	0.000427	0.00572	CcSEcCtD
Loperamide—Asthenia—Galantamine—Alzheimer's disease	0.000427	0.00572	CcSEcCtD
Loperamide—OPRK1—brain—Alzheimer's disease	0.000425	0.00546	CbGeAlD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000424	0.00569	CcSEcCtD
Loperamide—Discomfort—Rivastigmine—Alzheimer's disease	0.000422	0.00566	CcSEcCtD
Loperamide—Dry mouth—Rivastigmine—Alzheimer's disease	0.000418	0.0056	CcSEcCtD
Loperamide—Nervous system disorder—Memantine—Alzheimer's disease	0.000411	0.0055	CcSEcCtD
Loperamide—Somnolence—Donepezil—Alzheimer's disease	0.00041	0.00549	CcSEcCtD
Loperamide—Diarrhoea—Galantamine—Alzheimer's disease	0.000407	0.00545	CcSEcCtD
Loperamide—Skin disorder—Memantine—Alzheimer's disease	0.000407	0.00545	CcSEcCtD
Loperamide—Haloperidol—GRIN2B—Alzheimer's disease	0.000406	0.219	CrCbGaD
Loperamide—Dyspepsia—Donepezil—Alzheimer's disease	0.000406	0.00544	CcSEcCtD
Loperamide—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000402	0.00538	CcSEcCtD
Loperamide—ABCB1—blood vessel—Alzheimer's disease	0.000398	0.00511	CbGeAlD
Loperamide—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000398	0.00533	CcSEcCtD
Loperamide—Skin disorder—Rivastigmine—Alzheimer's disease	0.000398	0.00533	CcSEcCtD
Loperamide—Fatigue—Donepezil—Alzheimer's disease	0.000398	0.00533	CcSEcCtD
Loperamide—OPRM1—nervous system—Alzheimer's disease	0.000395	0.00508	CbGeAlD
Loperamide—Constipation—Donepezil—Alzheimer's disease	0.000394	0.00528	CcSEcCtD
Loperamide—Dizziness—Galantamine—Alzheimer's disease	0.000394	0.00527	CcSEcCtD
Loperamide—OPRM1—central nervous system—Alzheimer's disease	0.000381	0.00489	CbGeAlD
Loperamide—Vomiting—Galantamine—Alzheimer's disease	0.000378	0.00507	CcSEcCtD
Loperamide—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000377	0.00505	CcSEcCtD
Loperamide—Rash—Galantamine—Alzheimer's disease	0.000375	0.00503	CcSEcCtD
Loperamide—Dermatitis—Galantamine—Alzheimer's disease	0.000375	0.00502	CcSEcCtD
Loperamide—Headache—Galantamine—Alzheimer's disease	0.000373	0.00499	CcSEcCtD
Loperamide—Somnolence—Memantine—Alzheimer's disease	0.000372	0.00499	CcSEcCtD
Loperamide—Dyspepsia—Memantine—Alzheimer's disease	0.000369	0.00494	CcSEcCtD
Loperamide—Urticaria—Donepezil—Alzheimer's disease	0.000366	0.00491	CcSEcCtD
Loperamide—Abdominal pain—Donepezil—Alzheimer's disease	0.000365	0.00488	CcSEcCtD
Loperamide—Somnolence—Rivastigmine—Alzheimer's disease	0.000364	0.00488	CcSEcCtD
Loperamide—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000362	0.00484	CcSEcCtD
Loperamide—Fatigue—Memantine—Alzheimer's disease	0.000361	0.00484	CcSEcCtD
Loperamide—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000361	0.00483	CcSEcCtD
Loperamide—Constipation—Memantine—Alzheimer's disease	0.000358	0.0048	CcSEcCtD
Loperamide—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000354	0.00474	CcSEcCtD
Loperamide—Nausea—Galantamine—Alzheimer's disease	0.000353	0.00474	CcSEcCtD
Loperamide—Fatigue—Rivastigmine—Alzheimer's disease	0.000353	0.00473	CcSEcCtD
Loperamide—Constipation—Rivastigmine—Alzheimer's disease	0.00035	0.00469	CcSEcCtD
Loperamide—CALM3—cerebellum—Alzheimer's disease	0.000344	0.00442	CbGeAlD
Loperamide—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000342	0.00459	CcSEcCtD
Loperamide—Hypersensitivity—Donepezil—Alzheimer's disease	0.00034	0.00455	CcSEcCtD
Loperamide—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000335	0.00449	CcSEcCtD
Loperamide—Urticaria—Memantine—Alzheimer's disease	0.000333	0.00446	CcSEcCtD
Loperamide—Abdominal pain—Memantine—Alzheimer's disease	0.000331	0.00443	CcSEcCtD
Loperamide—Asthenia—Donepezil—Alzheimer's disease	0.000331	0.00443	CcSEcCtD
Loperamide—Pruritus—Donepezil—Alzheimer's disease	0.000326	0.00437	CcSEcCtD
Loperamide—Urticaria—Rivastigmine—Alzheimer's disease	0.000325	0.00436	CcSEcCtD
Loperamide—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000324	0.00434	CcSEcCtD
Loperamide—Diarrhoea—Donepezil—Alzheimer's disease	0.000316	0.00423	CcSEcCtD
Loperamide—Hypersensitivity—Memantine—Alzheimer's disease	0.000309	0.00413	CcSEcCtD
Loperamide—Dizziness—Donepezil—Alzheimer's disease	0.000305	0.00409	CcSEcCtD
Loperamide—OPRM1—brain—Alzheimer's disease	0.000302	0.00388	CbGeAlD
Loperamide—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000302	0.00404	CcSEcCtD
Loperamide—Asthenia—Memantine—Alzheimer's disease	0.0003	0.00403	CcSEcCtD
Loperamide—Pruritus—Memantine—Alzheimer's disease	0.000296	0.00397	CcSEcCtD
Loperamide—Asthenia—Rivastigmine—Alzheimer's disease	0.000294	0.00394	CcSEcCtD
Loperamide—Vomiting—Donepezil—Alzheimer's disease	0.000293	0.00393	CcSEcCtD
Loperamide—CYP2D6—forebrain—Alzheimer's disease	0.000292	0.00375	CbGeAlD
Loperamide—Rash—Donepezil—Alzheimer's disease	0.000291	0.0039	CcSEcCtD
Loperamide—Dermatitis—Donepezil—Alzheimer's disease	0.000291	0.00389	CcSEcCtD
Loperamide—Pruritus—Rivastigmine—Alzheimer's disease	0.00029	0.00388	CcSEcCtD
Loperamide—Headache—Donepezil—Alzheimer's disease	0.000289	0.00387	CcSEcCtD
Loperamide—CALM2—nervous system—Alzheimer's disease	0.000287	0.00369	CbGeAlD
Loperamide—Diarrhoea—Memantine—Alzheimer's disease	0.000286	0.00384	CcSEcCtD
Loperamide—CALM1—nervous system—Alzheimer's disease	0.000286	0.00367	CbGeAlD
Loperamide—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00028	0.00376	CcSEcCtD
Loperamide—CALM3—brain—Alzheimer's disease	0.000279	0.00359	CbGeAlD
Loperamide—Toremifene—ESR1—Alzheimer's disease	0.000279	0.151	CrCbGaD
Loperamide—Dizziness—Memantine—Alzheimer's disease	0.000277	0.00371	CcSEcCtD
Loperamide—CALM2—central nervous system—Alzheimer's disease	0.000276	0.00355	CbGeAlD
Loperamide—CALM1—central nervous system—Alzheimer's disease	0.000275	0.00353	CbGeAlD
Loperamide—Nausea—Donepezil—Alzheimer's disease	0.000274	0.00367	CcSEcCtD
Loperamide—Dizziness—Rivastigmine—Alzheimer's disease	0.000271	0.00363	CcSEcCtD
Loperamide—CALM2—cerebellum—Alzheimer's disease	0.00027	0.00347	CbGeAlD
Loperamide—CALM1—cerebellum—Alzheimer's disease	0.000269	0.00345	CbGeAlD
Loperamide—CYP2D6—telencephalon—Alzheimer's disease	0.000269	0.00345	CbGeAlD
Loperamide—Vomiting—Memantine—Alzheimer's disease	0.000266	0.00357	CcSEcCtD
Loperamide—Rash—Memantine—Alzheimer's disease	0.000264	0.00354	CcSEcCtD
Loperamide—Dermatitis—Memantine—Alzheimer's disease	0.000264	0.00353	CcSEcCtD
Loperamide—Headache—Memantine—Alzheimer's disease	0.000262	0.00351	CcSEcCtD
Loperamide—Vomiting—Rivastigmine—Alzheimer's disease	0.00026	0.00349	CcSEcCtD
Loperamide—Rash—Rivastigmine—Alzheimer's disease	0.000258	0.00346	CcSEcCtD
Loperamide—Dermatitis—Rivastigmine—Alzheimer's disease	0.000258	0.00346	CcSEcCtD
Loperamide—Headache—Rivastigmine—Alzheimer's disease	0.000257	0.00344	CcSEcCtD
Loperamide—Nausea—Memantine—Alzheimer's disease	0.000249	0.00333	CcSEcCtD
Loperamide—Nausea—Rivastigmine—Alzheimer's disease	0.000243	0.00326	CcSEcCtD
Loperamide—ABCB1—embryo—Alzheimer's disease	0.000238	0.00305	CbGeAlD
Loperamide—CALM2—brain—Alzheimer's disease	0.000219	0.00282	CbGeAlD
Loperamide—CALM1—brain—Alzheimer's disease	0.000218	0.0028	CbGeAlD
Loperamide—CYP2B6—nervous system—Alzheimer's disease	0.000213	0.00274	CbGeAlD
Loperamide—ABCB1—forebrain—Alzheimer's disease	0.00021	0.0027	CbGeAlD
Loperamide—Clemastine—CYP2D6—Alzheimer's disease	0.000209	0.113	CrCbGaD
Loperamide—CYP2B6—central nervous system—Alzheimer's disease	0.000205	0.00264	CbGeAlD
Loperamide—ABCB1—telencephalon—Alzheimer's disease	0.000193	0.00248	CbGeAlD
Loperamide—CYP2C8—brain—Alzheimer's disease	0.000182	0.00233	CbGeAlD
Loperamide—CYP2B6—brain—Alzheimer's disease	0.000163	0.00209	CbGeAlD
Loperamide—CYP3A4—nervous system—Alzheimer's disease	0.000161	0.00207	CbGeAlD
Loperamide—CYP2D6—nervous system—Alzheimer's disease	0.000159	0.00204	CbGeAlD
Loperamide—CYP3A4—central nervous system—Alzheimer's disease	0.000155	0.00199	CbGeAlD
Loperamide—CYP2D6—central nervous system—Alzheimer's disease	0.000153	0.00196	CbGeAlD
Loperamide—CYP2D6—cerebellum—Alzheimer's disease	0.000149	0.00192	CbGeAlD
Loperamide—Darifenacin—CYP2D6—Alzheimer's disease	0.000149	0.0805	CrCbGaD
Loperamide—Fexofenadine—CYP2D6—Alzheimer's disease	0.000145	0.0783	CrCbGaD
Loperamide—CYP2D6—brain—Alzheimer's disease	0.000121	0.00156	CbGeAlD
Loperamide—ABCB1—nervous system—Alzheimer's disease	0.000114	0.00146	CbGeAlD
Loperamide—Clotrimazole—CYP2D6—Alzheimer's disease	0.000112	0.0605	CrCbGaD
Loperamide—Tamoxifen—ESR1—Alzheimer's disease	0.000111	0.0601	CrCbGaD
Loperamide—Haloperidol—HTR2A—Alzheimer's disease	0.00011	0.0596	CrCbGaD
Loperamide—ABCB1—central nervous system—Alzheimer's disease	0.00011	0.00141	CbGeAlD
Loperamide—ABCB1—cerebellum—Alzheimer's disease	0.000107	0.00138	CbGeAlD
Loperamide—Haloperidol—CYP2D6—Alzheimer's disease	0.000101	0.0545	CrCbGaD
Loperamide—Dextropropoxyphene—CYP2D6—Alzheimer's disease	9.69e-05	0.0523	CrCbGaD
Loperamide—ABCB1—brain—Alzheimer's disease	8.72e-05	0.00112	CbGeAlD
Loperamide—Tamoxifen—CYP2D6—Alzheimer's disease	6.63e-05	0.0358	CrCbGaD
Loperamide—Methadone—CYP2D6—Alzheimer's disease	6.57e-05	0.0355	CrCbGaD
Loperamide—CALM3—Disease—GSK3B—Alzheimer's disease	2.84e-06	2.18e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—CALM1—Alzheimer's disease	2.84e-06	2.17e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—APOE—Alzheimer's disease	2.83e-06	2.17e-05	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.82e-06	2.16e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—CREB1—Alzheimer's disease	2.82e-06	2.16e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—A2M—Alzheimer's disease	2.82e-06	2.16e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—INS—Alzheimer's disease	2.8e-06	2.15e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—CAV1—Alzheimer's disease	2.8e-06	2.15e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—CASP3—Alzheimer's disease	2.8e-06	2.14e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—NOS3—Alzheimer's disease	2.78e-06	2.13e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—IL6—Alzheimer's disease	2.78e-06	2.13e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IGF1R—Alzheimer's disease	2.77e-06	2.12e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IGF1R—Alzheimer's disease	2.77e-06	2.12e-05	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—TP53—Alzheimer's disease	2.77e-06	2.12e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—CALM1—Alzheimer's disease	2.76e-06	2.11e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—GSK3B—Alzheimer's disease	2.75e-06	2.11e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—GSK3B—Alzheimer's disease	2.75e-06	2.11e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—APOE—Alzheimer's disease	2.75e-06	2.11e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—LPL—Alzheimer's disease	2.74e-06	2.1e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	2.73e-06	2.09e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—CREB1—Alzheimer's disease	2.73e-06	2.09e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—CREB1—Alzheimer's disease	2.73e-06	2.09e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—CAV1—Alzheimer's disease	2.72e-06	2.09e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MEF2C—Alzheimer's disease	2.72e-06	2.08e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—HMOX1—Alzheimer's disease	2.72e-06	2.08e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—INS—Alzheimer's disease	2.71e-06	2.08e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—INS—Alzheimer's disease	2.71e-06	2.08e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—VEGFA—Alzheimer's disease	2.71e-06	2.07e-05	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—TP53—Alzheimer's disease	2.68e-06	2.05e-05	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—TP53—Alzheimer's disease	2.68e-06	2.05e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—CALM1—Alzheimer's disease	2.67e-06	2.05e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—PRKCG—Alzheimer's disease	2.67e-06	2.04e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—APOE—Alzheimer's disease	2.66e-06	2.04e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—APOE—Alzheimer's disease	2.66e-06	2.04e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—LPL—Alzheimer's disease	2.65e-06	2.03e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—LPL—Alzheimer's disease	2.65e-06	2.03e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—CAV1—Alzheimer's disease	2.64e-06	2.02e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—CAV1—Alzheimer's disease	2.64e-06	2.02e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MEF2C—Alzheimer's disease	2.63e-06	2.02e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MEF2C—Alzheimer's disease	2.63e-06	2.02e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—NGF—Alzheimer's disease	2.6e-06	1.99e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—PRKCG—Alzheimer's disease	2.58e-06	1.98e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—PRKCG—Alzheimer's disease	2.58e-06	1.98e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	2.57e-06	1.97e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—MTHFR—Alzheimer's disease	2.57e-06	1.97e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—MAPK8—Alzheimer's disease	2.57e-06	1.97e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—BCL2—Alzheimer's disease	2.57e-06	1.97e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—AKT1—Alzheimer's disease	2.56e-06	1.96e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	2.56e-06	1.96e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CCR5—Alzheimer's disease	2.53e-06	1.94e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—NGF—Alzheimer's disease	2.51e-06	1.93e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—NGF—Alzheimer's disease	2.51e-06	1.93e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—LPL—Alzheimer's disease	2.49e-06	1.91e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—TGFB1—Alzheimer's disease	2.48e-06	1.9e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—BCL2—Alzheimer's disease	2.48e-06	1.9e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—BCL2—Alzheimer's disease	2.48e-06	1.9e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—HTR2A—Alzheimer's disease	2.47e-06	1.9e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—PPARG—Alzheimer's disease	2.46e-06	1.89e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—NOS3—Alzheimer's disease	2.46e-06	1.89e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ACHE—Alzheimer's disease	2.45e-06	1.88e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CCR5—Alzheimer's disease	2.44e-06	1.87e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CCR5—Alzheimer's disease	2.44e-06	1.87e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	2.42e-06	1.86e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—INS—Alzheimer's disease	2.41e-06	1.85e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—CALM1—Alzheimer's disease	2.4e-06	1.84e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—PPARG—Alzheimer's disease	2.4e-06	1.84e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—HTR2A—Alzheimer's disease	2.39e-06	1.83e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—HTR2A—Alzheimer's disease	2.39e-06	1.83e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—APOE—Alzheimer's disease	2.39e-06	1.83e-05	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.38e-06	1.83e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—NOS3—Alzheimer's disease	2.38e-06	1.82e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—NOS3—Alzheimer's disease	2.38e-06	1.82e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—VEGFA—Alzheimer's disease	2.37e-06	1.82e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—CAV1—Alzheimer's disease	2.37e-06	1.82e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—CASP3—Alzheimer's disease	2.36e-06	1.81e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—INS—Alzheimer's disease	2.35e-06	1.8e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—IL6—Alzheimer's disease	2.35e-06	1.8e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—LPL—Alzheimer's disease	2.34e-06	1.8e-05	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—AKT1—Alzheimer's disease	2.34e-06	1.79e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—PPARG—Alzheimer's disease	2.32e-06	1.78e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—PPARG—Alzheimer's disease	2.32e-06	1.78e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CALM1—Alzheimer's disease	2.31e-06	1.77e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—LEP—Alzheimer's disease	2.3e-06	1.76e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—APOE—Alzheimer's disease	2.3e-06	1.76e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	2.3e-06	1.76e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ENO1—Alzheimer's disease	2.3e-06	1.76e-05	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—IL6—Alzheimer's disease	2.28e-06	1.75e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CAV1—Alzheimer's disease	2.28e-06	1.75e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—INS—Alzheimer's disease	2.27e-06	1.74e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—INS—Alzheimer's disease	2.27e-06	1.74e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL1B—Alzheimer's disease	2.27e-06	1.74e-05	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—AKT1—Alzheimer's disease	2.26e-06	1.73e-05	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—AKT1—Alzheimer's disease	2.26e-06	1.73e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	2.25e-06	1.73e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—PTGS2—Alzheimer's disease	2.25e-06	1.72e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—MTHFR—Alzheimer's disease	2.24e-06	1.72e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CALM1—Alzheimer's disease	2.23e-06	1.71e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—LEP—Alzheimer's disease	2.22e-06	1.7e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—APOE—Alzheimer's disease	2.22e-06	1.7e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—APOE—Alzheimer's disease	2.22e-06	1.7e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—LEP—Alzheimer's disease	2.22e-06	1.7e-05	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—IL6—Alzheimer's disease	2.2e-06	1.69e-05	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—IL6—Alzheimer's disease	2.2e-06	1.69e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CAV1—Alzheimer's disease	2.2e-06	1.69e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CAV1—Alzheimer's disease	2.2e-06	1.69e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—ESR1—Alzheimer's disease	2.2e-06	1.68e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL1B—Alzheimer's disease	2.19e-06	1.68e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL1B—Alzheimer's disease	2.19e-06	1.68e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TGFB1—Alzheimer's disease	2.18e-06	1.67e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—PTGS2—Alzheimer's disease	2.18e-06	1.67e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—PTGS2—Alzheimer's disease	2.18e-06	1.67e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—MAPK8—Alzheimer's disease	2.17e-06	1.66e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—F2—Alzheimer's disease	2.17e-06	1.66e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—AKT1—Alzheimer's disease	2.17e-06	1.66e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—BCHE—Alzheimer's disease	2.13e-06	1.64e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—ESR1—Alzheimer's disease	2.12e-06	1.63e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—ESR1—Alzheimer's disease	2.12e-06	1.63e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—NOTCH1—Alzheimer's disease	2.12e-06	1.63e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—NOS3—Alzheimer's disease	2.12e-06	1.62e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	2.11e-06	1.62e-05	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—AKT1—Alzheimer's disease	2.1e-06	1.61e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—F2—Alzheimer's disease	2.1e-06	1.61e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—F2—Alzheimer's disease	2.1e-06	1.61e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—CALM1—Alzheimer's disease	2.09e-06	1.6e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—APOE—Alzheimer's disease	2.08e-06	1.6e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PPARG—Alzheimer's disease	2.08e-06	1.6e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—MAPK8—Alzheimer's disease	2.08e-06	1.59e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—CAV1—Alzheimer's disease	2.06e-06	1.58e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—NOS3—Alzheimer's disease	2.06e-06	1.58e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—NOTCH1—Alzheimer's disease	2.05e-06	1.57e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—NOTCH1—Alzheimer's disease	2.05e-06	1.57e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—TP53—Alzheimer's disease	2.04e-06	1.57e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—INS—Alzheimer's disease	2.04e-06	1.57e-05	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—AKT1—Alzheimer's disease	2.03e-06	1.56e-05	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—AKT1—Alzheimer's disease	2.03e-06	1.56e-05	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—AKT1—Alzheimer's disease	2.02e-06	1.55e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	2.01e-06	1.54e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—MAPK8—Alzheimer's disease	2.01e-06	1.54e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—MAPK8—Alzheimer's disease	2.01e-06	1.54e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—VEGFA—Alzheimer's disease	2e-06	1.54e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—NOS3—Alzheimer's disease	1.99e-06	1.53e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—NOS3—Alzheimer's disease	1.99e-06	1.53e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—GSK3B—Alzheimer's disease	1.99e-06	1.53e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CREB1—Alzheimer's disease	1.98e-06	1.51e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—CALM1—Alzheimer's disease	1.97e-06	1.51e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—INS—Alzheimer's disease	1.96e-06	1.51e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—APOE—Alzheimer's disease	1.96e-06	1.51e-05	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—AKT1—Alzheimer's disease	1.95e-06	1.5e-05	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—AKT1—Alzheimer's disease	1.95e-06	1.5e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.95e-06	1.5e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—CAV1—Alzheimer's disease	1.95e-06	1.49e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—PTGS2—Alzheimer's disease	1.94e-06	1.48e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CCL2—Alzheimer's disease	1.93e-06	1.48e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—GSK3B—Alzheimer's disease	1.93e-06	1.48e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—GSK3B—Alzheimer's disease	1.93e-06	1.48e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CREB1—Alzheimer's disease	1.91e-06	1.46e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CREB1—Alzheimer's disease	1.91e-06	1.46e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—INS—Alzheimer's disease	1.9e-06	1.46e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—INS—Alzheimer's disease	1.9e-06	1.46e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IGF1—Alzheimer's disease	1.9e-06	1.46e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—PTGS2—Alzheimer's disease	1.88e-06	1.44e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—IL6—Alzheimer's disease	1.87e-06	1.43e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CCL2—Alzheimer's disease	1.87e-06	1.43e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CCL2—Alzheimer's disease	1.87e-06	1.43e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TGFB1—Alzheimer's disease	1.84e-06	1.41e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IGF1—Alzheimer's disease	1.84e-06	1.41e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IGF1—Alzheimer's disease	1.84e-06	1.41e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—PTGS2—Alzheimer's disease	1.82e-06	1.4e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—PTGS2—Alzheimer's disease	1.82e-06	1.4e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PPARG—Alzheimer's disease	1.82e-06	1.39e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TP53—Alzheimer's disease	1.79e-06	1.37e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—NOS3—Alzheimer's disease	1.79e-06	1.37e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—INS—Alzheimer's disease	1.78e-06	1.36e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—AKT1—Alzheimer's disease	1.73e-06	1.32e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—NOS3—Alzheimer's disease	1.72e-06	1.32e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PPARG—Alzheimer's disease	1.71e-06	1.31e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.68e-06	1.29e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—INS—Alzheimer's disease	1.68e-06	1.29e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.67e-06	1.28e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—NOS3—Alzheimer's disease	1.67e-06	1.28e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—NOS3—Alzheimer's disease	1.67e-06	1.28e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—IL6—Alzheimer's disease	1.64e-06	1.26e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	1.64e-06	1.26e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—TGFB1—Alzheimer's disease	1.63e-06	1.25e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—TGFB1—Alzheimer's disease	1.57e-06	1.21e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—TGFB1—Alzheimer's disease	1.57e-06	1.21e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—NOS3—Alzheimer's disease	1.56e-06	1.2e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.53e-06	1.17e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TP53—Alzheimer's disease	1.51e-06	1.16e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—AKT1—Alzheimer's disease	1.51e-06	1.16e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.47e-06	1.13e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CASP3—Alzheimer's disease	1.46e-06	1.12e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—IL6—Alzheimer's disease	1.45e-06	1.11e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PTGS2—Alzheimer's disease	1.43e-06	1.09e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CASP3—Alzheimer's disease	1.41e-06	1.08e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CASP3—Alzheimer's disease	1.41e-06	1.08e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—IL6—Alzheimer's disease	1.41e-06	1.08e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—IL6—Alzheimer's disease	1.41e-06	1.08e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—IL6—Alzheimer's disease	1.39e-06	1.06e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.38e-06	1.06e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.35e-06	1.03e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MAPK8—Alzheimer's disease	1.34e-06	1.03e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—AKT1—Alzheimer's disease	1.34e-06	1.03e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL6—Alzheimer's disease	1.33e-06	1.02e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MAPK8—Alzheimer's disease	1.3e-06	9.97e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MAPK8—Alzheimer's disease	1.3e-06	9.97e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—AKT1—Alzheimer's disease	1.3e-06	9.94e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—AKT1—Alzheimer's disease	1.3e-06	9.94e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.29e-06	9.88e-06	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL6—Alzheimer's disease	1.28e-06	9.84e-06	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL6—Alzheimer's disease	1.28e-06	9.84e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.28e-06	9.84e-06	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—AKT1—Alzheimer's disease	1.28e-06	9.8e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.27e-06	9.75e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—VEGFA—Alzheimer's disease	1.24e-06	9.51e-06	CbGpPWpGaD
Loperamide—CALM3—Disease—IL6—Alzheimer's disease	1.23e-06	9.39e-06	CbGpPWpGaD
Loperamide—CALM3—Immune System—AKT1—Alzheimer's disease	1.22e-06	9.39e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—VEGFA—Alzheimer's disease	1.2e-06	9.2e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—VEGFA—Alzheimer's disease	1.2e-06	9.2e-06	CbGpPWpGaD
Loperamide—CALM2—Disease—IL6—Alzheimer's disease	1.19e-06	9.09e-06	CbGpPWpGaD
Loperamide—CALM1—Disease—IL6—Alzheimer's disease	1.19e-06	9.09e-06	CbGpPWpGaD
Loperamide—CALM2—Immune System—AKT1—Alzheimer's disease	1.18e-06	9.08e-06	CbGpPWpGaD
Loperamide—CALM1—Immune System—AKT1—Alzheimer's disease	1.18e-06	9.08e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TGFB1—Alzheimer's disease	1.14e-06	8.73e-06	CbGpPWpGaD
Loperamide—CALM3—Disease—AKT1—Alzheimer's disease	1.13e-06	8.67e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.12e-06	8.57e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TGFB1—Alzheimer's disease	1.1e-06	8.44e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TGFB1—Alzheimer's disease	1.1e-06	8.44e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—INS—Alzheimer's disease	1.1e-06	8.41e-06	CbGpPWpGaD
Loperamide—CALM2—Disease—AKT1—Alzheimer's disease	1.09e-06	8.38e-06	CbGpPWpGaD
Loperamide—CALM1—Disease—AKT1—Alzheimer's disease	1.09e-06	8.38e-06	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—AKT1—Alzheimer's disease	9.73e-07	7.46e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—NOS3—Alzheimer's disease	9.62e-07	7.37e-06	CbGpPWpGaD
Loperamide—CALM3—Metabolism—AKT1—Alzheimer's disease	9.47e-07	7.26e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TP53—Alzheimer's disease	9.38e-07	7.19e-06	CbGpPWpGaD
Loperamide—CALM2—Metabolism—AKT1—Alzheimer's disease	9.16e-07	7.02e-06	CbGpPWpGaD
Loperamide—CALM1—Metabolism—AKT1—Alzheimer's disease	9.16e-07	7.02e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TP53—Alzheimer's disease	9.07e-07	6.95e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TP53—Alzheimer's disease	9.07e-07	6.95e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	8.8e-07	6.74e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IL6—Alzheimer's disease	8.58e-07	6.58e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IL6—Alzheimer's disease	8.3e-07	6.36e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IL6—Alzheimer's disease	8.3e-07	6.36e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—AKT1—Alzheimer's disease	8.24e-07	6.31e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—AKT1—Alzheimer's disease	7.92e-07	6.07e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—AKT1—Alzheimer's disease	7.66e-07	5.87e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—AKT1—Alzheimer's disease	7.66e-07	5.87e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—AKT1—Alzheimer's disease	7.18e-07	5.5e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—AKT1—Alzheimer's disease	6.76e-07	5.18e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—AKT1—Alzheimer's disease	4.42e-07	3.39e-06	CbGpPWpGaD
